Published October 24, 2013
| Version v1
Journal article
Open
Partitioning the Heritability of Tourette Syndrome and Obsessive Compulsive Disorder Reveals Differences in Genetic Architecture
Creators
- Davis, Lea K.1
- Yu, Dongmei2
- Keenan, Clare L.1
- Gamazon, Eric R.1
- Konkashbaev, Anuar I.1
- Derks, Eske M.3
- Neale, Benjamin M.4
- Yang, Jian5
- Lee, S. Hong5
- Evans, Patrick1
- Barr, Cathy L.6
- Bellodi, Laura7
- Benarroch, Fortu8
- Berrio, Gabriel Bedoya9
- Bienvenu, Oscar J.10
- Bloch, Michael H.11
- Blom, Rianne M.3
- Bruun, Ruth D.12
- Budman, Cathy L.12
- Camarena, Beatriz13
- 1. University of Chicago
- 2. Harvard University
- 3. University of Amsterdam
- 4. Massachusetts General Hospital
- 5. University of Queensland
- 6. The Toronto Western Research Institute
- 7. Università Vita-Salute San Raffaele
- 8. Hadassah-Hebrew University Medical Center
- 9. Universidad Pontificia Bolivariana
- 10. Johns Hopkins University
- 11. Yale University
- 12. North Shore-Long Island Jewish Health System
- 13. Instituto Nacional de Psiquiatría Ramon de la Fuente Muñiz
Description
The direct estimation of heritability from genome-wide common variant data as implemented in the program Genome-wide Complex Trait Analysis (GCTA) has provided a means to quantify heritability attributable to all interrogated variants. We have quantified the variance in liability to disease explained by all SNPs for two phenotypically-related neurobehavioral disorders, obsessive-compulsive disorder (OCD) and Tourette Syndrome (TS), using GCTA. Our analysis yielded a heritability point estimate of 0.58 (se = 0.09, p = 5.64e-12) for TS, and 0.37 (se = 0.07, p = 1.5e-07) for OCD. In addition, we conducted multiple genomic partitioning analyses to identify genomic elements that concentrate this heritability. We examined genomic architectures of TS and OCD by chromosome, MAF bin, and functional annotations. In addition, we assessed heritability for early onset and adult onset OCD. Among other notable results, we found that SNPs with a minor allele frequency of less than 5% accounted for 21% of the TS heritability and 0% of the OCD heritability. Additionally, we identified a significant contribution to TS and OCD heritability by variants significantly associated with gene expression in two regions of the brain (parietal cortex and cerebellum) for which we had available expression quantitative trait loci (eQTLs). Finally we analyzed the genetic correlation between TS and OCD, revealing a genetic correlation of 0.41 (se = 0.15, p = 0.002). These results are very close to previous heritability estimates for TS and OCD based on twin and family studies, suggesting that very little, if any, heritability is truly missing (i.e., unassayed) from TS and OCD GWAS studies of common variation. The results also indicate that there is some genetic overlap between these two phenotypically-related neuropsychiatric disorders, but suggest that the two disorders have distinct genetic architectures.
Notes
Files
journal.pgen.1003864.pdf
Files
(1.1 MB)
| Name | Size | Download all |
|---|---|---|
|
Article md5:437d2a27dc80379e2b90d7ee691207ec |
652.6 kB | Preview Download |
|
md5:6f32cdb04ed0ff6b9e67d89c46d2f8fd
|
477.2 kB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1371/journal.pgen.1003864
- Other
- oai:uchicago.tind.io:10895
Funding
- Allison Family Foundation
- American Academy of Child and Adolescent Psychiatry
- Anxiety and Depression Association of America
- Australian Research Council
- Deutsche Forschungsgemeinschaft
- 1912/1-1
- Division of Social and Economic Sciences
- Eli Lilly (Canada)
- Unknown funder
- Great-West Life Assurance Company of Canada
- Unknown funder
- Italian Tourette Syndrome Association
- Unknown funder
- Italian Tourette Syndrome Association
- John Wiley & Sons (United States)
- Medical Research Council
- National Health and Medical Research Council
- National Institute of Mental Health
- National Institute of Neurological Disorders and Stroke
- National Institute on Alcohol Abuse and Alcoholism
- National Institute on Drug Abuse
- National Institutes of Health
- 1R01MH079487-01A1
- National Institutes of Health
- K20 MH01065
- National Institutes of Health
- MH073250
- National Institutes of Health
- MH079489
- National Institutes of Health
- MH085057
- National Institutes of Health
- NS037484
- National Institutes of Health
- NS16648
- National Institutes of Health
- NS40024
- National Institutes of Health
- R01 MH58376
- Unknown funder
- SynapDx
- Tourette Association of America
- Unknown funder
- Tourette Syndrome Foundation of Canada
- Tourettes Action
- National Institute of Mental Health
- K08 MH099424-01
- National Institute of Mental Health
- R01MH092293
- Eli Lilly (United States)
- U01HG004446
- AstraZeneca (United States)
- Novartis (United States)
- Roche (United States)
- Janssen (United States)
- European Commission
- Deutsche Forschungsgemeinschaft
- Swiss National Science Foundation
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Takeda (United States)
- Lundbeck (United States)
- Kanton Zürich
- HSM Hochspezialisierte Medizin
- Ontario Mental Health Foundation